Clinical Trial Update: Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adoptive cell therapy after a reduced intensity, non-myeloablative lymphodepleting induction in metastatic ovarian canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Sheba Medical Center | Conditions: Metastatic Ovarian Cancer | Phase 2 | Status: UNKNOWN